These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 31571622)

  • 1. Heterozygous lys169Glu mutation of glucokinase gene in a Chinese family having glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Zhou W; Chen M; Zhou H; Zhang Z
    J Postgrad Med; 2019; 65(4):241-243. PubMed ID: 31571622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features.
    Hughes AE; De Franco E; Globa E; Zelinska N; Hilgard D; Sifianou P; Hattersley AT; Flanagan SE
    Pediatr Diabetes; 2021 Sep; 22(6):876-881. PubMed ID: 34085361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional analysis of GCK gene mutations in 12 Chinese families with hyperglycemia.
    Wang Z; Diao C; Liu Y; Li M; Zheng J; Zhang Q; Yu M; Zhang H; Ping F; Li M; Xiao X
    J Diabetes Investig; 2019 Jul; 10(4):963-971. PubMed ID: 30592380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
    Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
    Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable presentations of
    Oza CM; Karguppikar MB; Khadilkar V; Khadilkar A
    BMJ Case Rep; 2022 Feb; 15(2):. PubMed ID: 35228227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young.
    Wang T; Zhu M; Wang Y; Hu C; Fang C; Hu J
    Endocrine; 2024 Jan; 83(1):92-98. PubMed ID: 37847371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution- and structure-based computational strategy reveals the impact of deleterious missense mutations on MODY 2 (maturity-onset diabetes of the young, type 2).
    George DC; Chakraborty C; Haneef SA; Nagasundaram N; Chen L; Zhu H
    Theranostics; 2014; 4(4):366-85. PubMed ID: 24578721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing.
    Hughes AE; Houghton JAL; Bunce B; Chakera AJ; Spyer G; Shepherd MH; Flanagan SE; Hattersley AT
    Diabetologia; 2023 Nov; 66(11):1997-2006. PubMed ID: 37653058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial GCK gene deletion mutations causing maturity-onset diabetes of the young.
    Yu R; Zhang H; Xiao X
    Acta Diabetol; 2024 Jan; 61(1):107-115. PubMed ID: 37704826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the pathogenicity of rare missense GCK variants from the identification and functional characterization of compound heterozygous and double mutations inherited in cis.
    Beer NL; Osbak KK; van de Bunt M; Tribble ND; Steele AM; Wensley KJ; Edghill EL; Colcough K; Barrett A; Valentínová L; Rundle JK; Raimondo A; Grimsby J; Ellard S; Gloyn AL
    Diabetes Care; 2012 Jul; 35(7):1482-4. PubMed ID: 22611063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TWO OPPOSITE PHENOTYPES OF GLUCOSE DISORDERS IN A FAMILY WITH HETEROZYGOUS P.SER453LEU (C.1358C> T) MUTATION IN THE GLUCOKINASE (GCK) GENE: MATURITY ONSET DIABETES IN YOUNG AND INSULINOMA.
    Demiral M; Çelebi HBG; Cander S; Yerci O; Eren E; Demirbilek H
    Acta Endocrinol (Buchar); 2022; 18(4):458-465. PubMed ID: 37152879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.
    Steele AM; Shields BM; Wensley KJ; Colclough K; Ellard S; Hattersley AT
    JAMA; 2014 Jan; 311(3):279-86. PubMed ID: 24430320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comprehensive map of human glucokinase variant activity.
    Gersing S; Cagiada M; Gebbia M; Gjesing AP; Coté AG; Seesankar G; Li R; Tabet D; Weile J; Stein A; Gloyn AL; Hansen T; Roth FP; Lindorff-Larsen K; Hartmann-Petersen R
    Genome Biol; 2023 Apr; 24(1):97. PubMed ID: 37101203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The previously reported T342P GCK missense variant is not a pathogenic mutation causing MODY.
    Steele AM; Tribble ND; Caswell R; Wensley KJ; Hattersley AT; Gloyn AL; Ellard S
    Diabetologia; 2011 Aug; 54(8):2202-5. PubMed ID: 21604084
    [No Abstract]   [Full Text] [Related]  

  • 17. Generation of N-ethyl-N-nitrosourea (ENU) diabetes models in mice demonstrates genotype-specific action of glucokinase activators.
    Fenner D; Odili S; Hong HK; Kobayashi Y; Kohsaka A; Siepka SM; Vitaterna MH; Chen P; Zelent B; Grimsby J; Takahashi JS; Matschinsky FM; Bass J
    J Biol Chem; 2011 Nov; 286(45):39560-72. PubMed ID: 21921030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2).
    Gregory JM; Smith TJ; Slaughter JC; Mason HR; Hughey CC; Smith MS; Kandasamy B; Greeley SAW; Philipson LH; Naylor RN; Letourneau LR; Abumrad NN; Cherrington AD; Moore DJ
    Diabetes; 2019 Aug; 68(8):1565-1576. PubMed ID: 31092478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing of GCK-MODY identifies a novel pathogenic variant in a Chinese boy with early onset hyperglycemia.
    Poon KS; Tan KM; Koay ES; Sng A
    Hum Genome Var; 2020; 7():7. PubMed ID: 32257292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial adult onset hyperinsulinism due to an activating glucokinase mutation: implications for pharmacological glucokinase activation.
    Challis BG; Harris J; Sleigh A; Isaac I; Orme SM; Seevaratnam N; Dhatariya K; Simpson HL; Semple RK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):855-61. PubMed ID: 24890200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.